| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $198 | 1 | 100 |
| Telling Fred | director | 0 | $0 | 1 | $198 | $-198 |
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed …
Over the last 12 months, insiders at Oragenics, Inc. have bought $0 and sold $198 worth of Oragenics, Inc. stock.
On average, over the past 5 years, insiders at Oragenics, Inc. have bought $607,355 and sold $53,782 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,084 shares for transaction amount of $2,884 was made by Telling Fred () on 2022‑06‑17.
| 2025-12-12 | Sale | Telling Fred | director | 210 0.0052% | $0.94 | $198 | -35.45% | |
| 2025-06-18 | Sale | Odyssey Health, Inc. | 10 percent owner | 5,044 0.8091% | $4.26 | $21,487 | -75.74% | |
| 2025-06-17 | Sale | Odyssey Health, Inc. | 10 percent owner | 2,000 0.2851% | $4.46 | $8,920 | -79.18% | |
| 2025-06-16 | Sale | Odyssey Health, Inc. | 10 percent owner | 5,000 0.7145% | $4.45 | $22,250 | -79.01% | |
| 2025-06-13 | Sale | Odyssey Health, Inc. | 10 percent owner | 5,000 0.6841% | $4.27 | $21,350 | -78.97% | |
| 2024-12-06 | Sale | Telling Fred | director | 3,597 0.0303% | $0.36 | $1,295 | -61.41% | |
| 2024-12-06 | Sale | DUNTON ALAN W | director | 66 0.0006% | $0.36 | $24 | -61.41% | |
| 2023-11-30 | Sale | Telling Fred | director | 3,500 0.3216% | $3.57 | $12,488 | -65.64% | |
| 2022-12-30 | Sale | KOSKI ROBERT C | director | 42,357 0.1151% | $0.11 | $4,469 | -45.61% | |
| 2022-12-29 | Sale | KOSKI ROBERT C | director | 36,648 0.1% | $0.11 | $3,885 | -48.03% | |
| 2022-12-15 | Sale | KOSKI ROBERT C | director | 140,497 0.636% | $0.18 | $24,699 | -66.33% | |
| 2022-12-14 | Sale | KOSKI ROBERT C | director | 29,503 0.1329% | $0.17 | $5,163 | -66.37% | |
| 2022-12-09 | Sale | KOSKI ROBERT C | director | 48,795 0.2475% | $0.20 | $9,613 | -69.51% | |
| 2022-12-08 | Sale | KOSKI ROBERT C | director | 13,036 0.0671% | $0.20 | $2,607 | -69.91% | |
| 2022-11-30 | Sale | KOSKI ROBERT C | director | 200,000 0.9841% | $0.19 | $38,220 | -70.87% | |
| 2022-11-29 | Sale | KOSKI ROBERT C | director | 200,000 0.9903% | $0.19 | $38,460 | -69.83% | |
| 2022-06-17 | Telling Fred | 10,084 0.0743% | $0.29 | $2,884 | -47.09% | |||
| 2022-05-23 | Telling Fred | director | 82,173 0.6123% | $0.29 | $23,780 | -31.79% | ||
| 2022-05-20 | Telling Fred | 65,718 0.4799% | $0.28 | $18,638 | -29.48% | |||
| 2022-05-19 | Telling Fred | director | 56,806 0.4106% | $0.28 | $15,945 | -29.29% |
| Telling Fred | director | 948 0.021% | $350.85 | 15 | 3 | +79.42% |
| KIRK RANDAL J | 10 percent owner | 14481089 320.9492% | $5.36M | 3 | 0 | |
| HAWES GEORGE T | 10 percent owner | 10857235 240.6325% | $4.02M | 5 | 19 | |
| HILLMAN JEFFREY D | Director | 4202394 93.1391% | $1.56M | 1 | 2 | |
| KOSKI ROBERT C | director | 1102295 24.4305% | $407,959.38 | 2 | 11 | |
| ZAHRADNIK ROBERT T | 881000 19.5259% | $326,058.10 | 1 | 0 | ||
| BONFIGLIO JOHN N | President and CEO | 385255 8.5385% | $142,582.88 | 2 | 0 | |
| KOSKI FAMILY LP | 10 percent owner | 277839 6.1578% | $102,828.21 | 26 | 7 | |
| GURY DAVID J | director | 125000 2.7704% | $46,262.50 | 2 | 0 | |
| Evens Ronald P | director | 113636 2.5186% | $42,056.68 | 1 | 0 | |
| Joslyn Alan | See Remarks | 66667 1.4776% | $24,673.46 | 1 | 0 | |
| Sullivan Michael O'Keefe | Interim PEO, CFO | 34255 0.7592% | $12,677.78 | 1 | 0 | |
| DUNTON ALAN W | director | 25623 0.5679% | $9,483.07 | 1 | 16 | |
| Bohunicky Brian John | CFO, Secretary and Treasurer | 25000 0.5541% | $9,252.50 | 1 | 0 | |
| ANDERSON BRIAN | director | 0 0% | $0 | 1 | 1 |
$6,974,678 | 45 | -14.98% | $4.63M | |
$633,070 | 27 | -5.89% | $2.04M | |
$8,249,886 | 17 | -47.87% | $399,787.00 | |
$117,515 | 16 | -27.38% | $1.66M | |
$24,098 | 12 | -21.64% | $1.44M |
| Increased Positions | 10 | +76.92% | 164,527 | +134.27% |
| Decreased Positions | 2 | -15.38% | 335 | -0.27% |
| New Positions | 5 | New | 104,371 | New |
| Sold Out Positions | 2 | Sold Out | 335 | Sold Out |
| Total Postitions | 21 | +61.54% | 286,727 | +134% |
| Clear Street Llc | $59.00 | 1.77% | 70,619 | +70,619 | New | 2025-06-30 |
| Drw Securities, Llc | $52.00 | 1.55% | 61,809 | +61,809 | New | 2025-09-30 |
| Sabby Management, Llc | $49.00 | 1.47% | 58,953 | +58,953 | New | 2025-09-30 |
| Blackrock, Inc. | $1.00 | 0.02% | 703 | +2 | +0.28% | 2025-09-30 |
| Allworth Financial Lp | $0 | 0.01% | 334 | +334 | New | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 271 | -1,621 | -85.68% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $0 | 0.01% | 208 | -457 | -68.72% | 2025-09-30 |
| Morgan Stanley | $0 | <0.01% | 138 | -11,774 | -98.84% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 36 | -15,510 | -99.77% | 2025-09-30 |
| Harbour Investments, Inc. | $0 | <0.01% | 34 | 0 | 0% | 2025-09-30 |